646 related articles for article (PubMed ID: 21844075)
1. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
[TBL] [Abstract][Full Text] [Related]
2. Renalguard system in high-risk patients for contrast-induced acute kidney injury.
Briguori C
Minerva Cardioangiol; 2012 Jun; 60(3):291-7. PubMed ID: 22653043
[TBL] [Abstract][Full Text] [Related]
3. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Briguori C; Visconti G; Ricciardelli B; Condorelli G;
EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
[TBL] [Abstract][Full Text] [Related]
4. Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
Lee SW; Kim WJ; Kim YH; Park SW; Park DW; Yun SC; Lee JY; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Suh J; Cho YH; Lee NH; Cheong SS; Yoo SY; Lee BK; Lee SG; Hyon MS; Shin WY; Lee SW; Jang JS; Park SJ
Am J Cardiol; 2011 May; 107(10):1447-52. PubMed ID: 21420063
[TBL] [Abstract][Full Text] [Related]
5. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
[TBL] [Abstract][Full Text] [Related]
6. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
[TBL] [Abstract][Full Text] [Related]
7. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
ACT Investigators
Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
[TBL] [Abstract][Full Text] [Related]
8. 20-Hour preprocedural hydration is not superior to 5-hour preprocedural hydration in the prevention of contrast-induced increases in serum creatinine and cystatin C.
Torigoe K; Tamura A; Watanabe T; Kadota J
Int J Cardiol; 2013 Sep; 167(5):2200-3. PubMed ID: 22717305
[TBL] [Abstract][Full Text] [Related]
9. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
Barbanti M; Gulino S; Capranzano P; Immè S; Sgroi C; Tamburino C; Ohno Y; Attizzani GF; Patanè M; Sicuso R; Pilato G; Di Landro A; Todaro D; Di Simone E; Picci A; Giannetto G; Costa G; Deste W; Giannazzo D; Grasso C; Capodanno D; Tamburino C
JACC Cardiovasc Interv; 2015 Oct; 8(12):1595-604. PubMed ID: 26386766
[TBL] [Abstract][Full Text] [Related]
10. RenalGuard system in high-risk patients for contrast-induced acute kidney injury.
Briguori C; Visconti G; Donahue M; De Micco F; Focaccio A; Golia B; Signoriello G; Ciardiello C; Donnarumma E; Condorelli G
Am Heart J; 2016 Mar; 173():67-76. PubMed ID: 26920598
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
12. Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.
Briguori C; D'Amore C; De Micco F; Signore N; Esposito G; Napolitano G; Focaccio A;
Catheter Cardiovasc Interv; 2020 Apr; 95(5):895-903. PubMed ID: 31282129
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
Brar SS; Aharonian V; Mansukhani P; Moore N; Shen AY; Jorgensen M; Dua A; Short L; Kane K
Lancet; 2014 May; 383(9931):1814-23. PubMed ID: 24856027
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
15. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Briguori C; Airoldi F; D'Andrea D; Bonizzoni E; Morici N; Focaccio A; Michev I; Montorfano M; Carlino M; Cosgrave J; Ricciardelli B; Colombo A
Circulation; 2007 Mar; 115(10):1211-7. PubMed ID: 17309916
[TBL] [Abstract][Full Text] [Related]
16. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
[TBL] [Abstract][Full Text] [Related]
17. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
Koc F; Ozdemir K; Kaya MG; Dogdu O; Vatankulu MA; Ayhan S; Erkorkmaz U; Sonmez O; Aygul MU; Kalay N; Kayrak M; Karabag T; Alihanoglu Y; Gunebakmaz O
Int J Cardiol; 2012 Mar; 155(3):418-23. PubMed ID: 21106264
[TBL] [Abstract][Full Text] [Related]
18. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
[TBL] [Abstract][Full Text] [Related]
19. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
[TBL] [Abstract][Full Text] [Related]
20. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
Masuda M; Yamada T; Mine T; Morita T; Tamaki S; Tsukamoto Y; Okuda K; Iwasaki Y; Hori M; Fukunami M
Am J Cardiol; 2007 Sep; 100(5):781-6. PubMed ID: 17719320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]